Illumina Inc. has reached a definitive agreement to acquire Santa Clara-based NextBio, Illumina announced on Oct. 28.

Terms of the deal were not disclosed.

Illumina (Nasdaq: ILMN), a San Diego-based DNA sequencing company, said it expects the transaction to close by month’s end.

NextBio’s specialty is clinical and genomic informatics. Illumina said that by adding NextBio’s platform, it could offer customers “enterprise-level bioinformatics solutions that accelerate the discovery of new associations between the human genome and disease, and, ultimately, enable the application of those discoveries within health care.”

Illumina said the announcement would not change the financial guidance it issued on Oct. 21. The company projected revenue to grow 22 percent and said it expected non-GAAP earnings per share of $1.75 to $1.77.

Illumina acquired Verinata Health and Advanced Liquid Logic in 2013.

— SDBJ Staff Report